Author Archives: Scalper1

Where Are The Next Stock Market Leaders? Check Groups

A new uptrend is likely to bring new leadership to the market. Medical groups such as biomedicals were the leaders in the cycle that began last mid-October and ended in July to August. For biomedicals and biotechs to resume leadership in the next cycle would be unusual. History shows that stock market leadership seldom repeats in back-to-back cycles. After a washout, a group needs time to repair its dented image. So for now, the individual

What The 3rd Quarter Tells Us About The Stock Market In October

As things currently stand, investments that are more likely to benefit from lower borrowing costs rather than higher ones have been winners. The demand for higher yielding stocks contradicts the idea that the Federal Reserve can demonstrate any genuine conviction when attempting to move the overnight lending rate higher. Relative strength for utilities and REITs in the stock world, as well as relative strength for investment grade debt in the bond universe, suggest that the Fed will barely bump overnight lending rates, if at all. Three months ago to the day (6/30), I served up a list of reasons for lowering one’s exposure to riskier assets . I discussed weakness in market internals where fewer and fewer corporate components of the Dow and S&P 500 had been propping up the popular U.S. benchmarks. I talked about the faster rate of deterioration in foreign stocks over domestic stocks via the Vanguard FTSE All-World ex-US ETF (NYSEARCA: VEU ):S PDR S&P 500 Trust ETF (NYSEARCA: SPY ) price ratio. Additionally, I highlighted exorbitant U.S. stock valuations, the Federal Reserve’s rate hike quagmire and the ominous risk aversion in credit spreads. Three months later (9/30), a wide variety of risk assets are trading near 52-week lows or near year-to-date lows. Higher yielding bonds via the PIMCO 0-5 Year High Yield Corporate Bond Index ETF (NYSEARCA: HYS ) as well as the iShares iBoxx $ High Yield Corporate Bond ETF (NYSEARCA: HYG ) are floundering in the basement. Energy via the Guggenheim S&P Equal Weight Energy ETF (NYSEARCA: RYE ) has broken down below the S&P 500’s correction lows of August 24, suggesting that a bounce in oil and gas may be premature. Even former leadership in the beloved biotech sector via the SPDR Biotech ETF (NYSEARCA: XBI ) reminds us that bearish drops of 33% can destroy wealth as quickly as it is accumulated. Is it true that, historically speaking, bull market rallies typically fend off 10%-19% pullbacks? Absolutely. Yet there is nothing typical about zero percent rate policy for roughly seven years. For that matter, there was nothing normal about the U.S. Federal Reserve’s quantitative easing experiment – an emergency endeavor where $3.75 trillion in electronic dollar credits were used to acquire government debt and mortgage-backed debt. And ever since its 3rd iteration came to an end eleven months ago, broad market index investments like the Vanguard Total Stock Market ETF (NYSEARCA: VTI ) have lost ground. The same thing happened in 2010 during “QE1.” Once it ended, risk assets had lost their mojo. Then in September of 2010, rumors swirled about the Fed engaging in a second round of quantitative easing (a.k.a. “QE2″). And then the bull rally was back in business. As things currently stand, investments that are more likely to benefit from lower borrowing costs rather than higher ones have been winners. Utilities and REITs are up over the last three months; in contrast, industrials, financials and retail have been battered. The demand for higher yielding stocks contradicts the idea that the Federal Reserve can demonstrate any genuine conviction when attempting to move the overnight lending rate higher. (Some seem to believe that the next significant move might even be to ease.) Relative strength for utilities and REITs in the stock world, as well as relative strength for investment grade debt in the bond universe, suggest that the Fed will barely bump overnight lending rates, if at all. Granted, the Federal Reserve would like to tell you the job growth is solid, even as chairwoman Yellen and her colleagues ignore the disappearance of high-paying manufacturing jobs on a daily basis. It has gotten so bad that, according to ADP, the manufacturing sector has experienced a net LOSS for 2015. Is it any wonder that the extraordinary growth of part-time service workers alongside the loss of full-time manufacturing positions have contributed to significant declines in median household income? Should we ignore the reality that 19.5% of the 25-54 year-old, working-aged population is not participating in the labor force (a.k.a. unemployed) – a percentage that has increased every year from 16.5% in the Great Recession to 19.5% today? These are not “retirees” that we’re talking about here. We are maintaining our lower-than-normal asset allocation for our moderate growth and income clients at Pacific Park Financial, Inc. During June-July, our equity exposure moved down from 65%-70% stock (e.g., growth, value, large, small, foreign, etc.), down to 50% (mostly large-cap domestic). Our income exposure moved down from 30%-35% (e.g., short, long, investment grade, high yield, etc.) down to 25% (almost exclusively investment grade). The 25% cash component that we’ve been holding? We would need to see a desire for greater risk through greater pursuit of high yield bonds at the expense of treasuries. We would want to see a pursuit of capital gains over safety in a rising price ratio for the PowerShares S&P 500 High Beta Portfolio ETF (NYSEARCA: SPHB ):iShares MSCI USA Minimum Volatility ETF (NYSEARCA: USMV ). The fact that the SPHB:USMV price ratio is near its lows for the year tells me that it is still better to be safe than sorrowful. Disclosure: Gary Gordon, MS, CFP is the president of Pacific Park Financial, Inc., a Registered Investment Adviser with the SEC. Gary Gordon, Pacific Park Financial, Inc, and/or its clients may hold positions in the ETFs, mutual funds, and/or any investment asset mentioned above. The commentary does not constitute individualized investment advice. The opinions offered herein are not personalized recommendations to buy, sell or hold securities. At times, issuers of exchange-traded products compensate Pacific Park Financial, Inc. or its subsidiaries for advertising at the ETF Expert web site. ETF Expert content is created independently of any advertising relationships.

FSTA: This Little Gem Of An ETF Is Beautiful When You Look Inside

Summary FSTA tracks one of my favorite sectors and there is nothing to hold against it. From the market capitalizations of the companies down to the top 10 holdings, everything looks intelligently designed. While many consumer staples ETFs would be scared to go overboard on tobacco, FSTA gets it. Consumer Staples funds should be loaded up on companies producing addictive products. I’m a little concerned about the sheer size of the allocations to Coca-Cola and Pepsi because of a movement towards healthier foods. I wouldn’t want to cut out those holdings because I think the distribution and branding systems give them moats for competing in healthy foods. One of the sectors I’ve come to like is the consumer staples sector. Unfortunately, many investors seem to be catching on to how desirable the sector allocation is when there are concerns of a new correction or recession. One of the funds that I’m considering is the Fidelity MSCI Consumer Staples Index ETF (NYSEARCA: FSTA ). I’ll be performing a substantial portion of my analysis along the lines of modern portfolio theory, so my goal is to find ways to minimize costs while achieving diversification to reduce my risk level. Expense Ratio The expense ratio on the Fidelity MSCI Consumer Staples Index ETF is only .12%. This fund gets my stamp of approval for giving investors consumer staples exposure at a very reasonable expense ratio. Market Cap The ETF has a focus on large capitalization companies, but investors should be worried if this chart looked different. The idea is to load up the portfolio on big companies that are designed to withstand negative events in the economy. I think large companies make more sense than smaller companies in that aspect because I want to see companies that are market leaders with strong pricing power in an established industry. Geography There really isn’t much to talk about here. This is all domestic equity. Sector This sector breakdown is excellent. Personally, I have a moral objection to companies that sell tobacco products because they cause cancer. On the other hand, I don’t have a moral objection to risk adjusted returns. The result of that conflict is that I have to admire the structure of this portfolio. I’d love to see a further breakdown in some categories such as beverages because I’d value having some alcohol in the portfolio as well. When I’m looking at consumer staples, I want companies that sell products that are absolutely addictive. This is just cold hard logic. Market leaders that can dictate pricing on addictive products are in the ideal position to survive recessions without a major drop in sales or earnings. Largest Holdings This is a solid batch of holdings. I don’t see a single company on the list that looks exposed to a recession. I’ll admit that having both Coca-Cola (NYSE: KO ) and Pepsi (NYSE: PEP ) at the top of the portfolio feels a little heavy. If I was going to tweak the portfolio a little, I might drop those two in favor of having a little more alcohol. My big concern about those companies is that I believe we are in a very long term shift towards healthier food and some of their branding value is going to be lost. The reason I would still want a significant allocation is because they are both masters of building brands and have established enormous distribution networks across the world. When (or if) that sustained shift to healthier foods does occur, I expect both Pepsi and Coke to be in position to buy up smaller companies with the right products and then run the products through their branding and distribution product. Simply put, even if they don’t have the right products yet, they have incredible economic moats that should help them acquire the right products and utilize those products better than smaller competitors could. As I’ve been going through consumer staples ETFs, I’ve noticed that Wal-Mart (NYSE: WMT ) is suspiciously absent from some of them. I think that is a mistake. I really like Wal-Mart as a dividend growth company and I think the employee wage issues are overblown . Building the Portfolio The sample portfolio I ran for this assessment is one that came out feeling a bit awkward. I’ve had some requests to include biotechnology ETFs and I decided it would be wise to also include in the related field of health care for a comparison. Since I wanted to create quite a bit of diversification, I put in 9 ETFs plus the S&P 500. The resulting portfolio is one that I think turned out to be too risky for most investors and certainly too risky for older investors. Despite that weakness, I opted to go with highlighting these ETFs in this manner because I think it is useful to show investors what it looks like when the allocations result in a suboptimal allocation. The weightings for each ETF in the portfolio are a simple 10% which results in 20% of the portfolio going to the combined Health Care and Biotechnology sectors. Outside of that we have one spot each for REITs, high yield bonds, TIPS, emerging market consumer staples, domestic consumer staples, foreign large capitalization firms, and long term bonds. The first thing I want to point out about these allocations are that for any older investor, running only 30% in bonds with 10% of that being high yield bonds is putting yourself in a fairly dangerous position. I will be highlighting the individual ETFs, but I would not endorse this portfolio as a whole. The portfolio assumes frequent rebalancing which would be a problem for short term trading outside of tax advantaged accounts unless the investor was going to rebalance by adding to their positions on a regular basis and allocating the majority of the capital towards whichever portions of the portfolio had been underperforming recently. Because a substantial portion of the yield from this portfolio comes from REITs and interest, I would favor this portfolio as a tax exempt strategy even if the investor was frequently rebalancing by adding new capital. The portfolio allocations can be seen below along with the dividend yields from each investment. Name Ticker Portfolio Weight Yield SPDR S&P 500 Trust ETF SPY 10.00% 2.11% Health Care Select Sect SPDR ETF XLV 10.00% 1.40% SPDR Biotech ETF XBI 10.00% 1.54% iShares U.S. Real Estate ETF IYR 10.00% 3.83% PowerShares Fundamental High Yield Corporate Bond Portfolio ETF PHB 10.00% 4.51% FlexShares iBoxx 3-Year Target Duration TIPS Index ETF TDTT 10.00% 0.16% EGShares Emerging Markets Consumer ETF ECON 10.00% 1.34% Fidelity MSCI Consumer Staples Index ETF FSTA 10.00% 2.99% iShares MSCI EAFE ETF EFA 10.00% 2.89% Vanguard Long-Term Bond ETF BLV 10.00% 4.02% Portfolio 100.00% 2.48% The next chart shows the annualized volatility and beta of the portfolio since October of 2013. (click to enlarge) Risk Contribution The risk contribution category demonstrates the amount of the portfolio’s volatility that can be attributed to that position. You can see immediately since this is a simple “equal weight” portfolio that XBI is by far the most risky ETF from the perspective of what it does to the portfolio’s volatility. You can also see that BLV has a negative total risk impact on the portfolio. When you see negative risk contributions in this kind of assessment it generally means that there will be significantly negative correlations with other asset classes in the portfolio. The position in TDTT is also unique for having a risk contribution of almost nothing. Unfortunately, it also provides a weak yield and weak return with little opportunity for that to change unless yields on TIPS improve substantially. If that happened, it would create a significant loss before the position would start generating meaningful levels of income. A quick rundown of the portfolio I put together the following chart that really simplifies the role of each investment: Name Ticker Role in Portfolio SPDR S&P 500 Trust ETF SPY Core of Portfolio Health Care Select Sect SPDR ETF XLV Hedge Risk of Higher Costs SPDR Biotech ETF XBI Increase Expected Return iShares U.S. Real Estate ETF IYR Diversify Domestic Risk PowerShares Fundamental High Yield Corporate Bond Portfolio ETF PHB Strong Yields on Bond Investments FlexShares iBoxx 3-Year Target Duration TIPS Index ETF TDTT Very Low Volatility EGShares Emerging Markets Consumer ETF ECON Enhance Foreign Exposure Fidelity MSCI Consumer Staples Index ETF FSTA Reduce Portfolio Risk iShares MSCI EAFE ETF EFA Enhance Foreign Exposure Vanguard Long-Term Bond ETF BLV Negative Correlation, Strong Yield Correlation The chart below shows the correlation of each ETF with each other ETF in the portfolio. Blue boxes indicate positive correlations and tan box indicate negative correlations. Generally speaking lower levels of correlation are highly desirable and high levels of correlation substantially reduce the benefits from diversification. (click to enlarge) Conclusion FSTA has a great expense ratio, great sector, and great allocations within the sector. This ETF is a slam dunk for long term holdings. The only concern I have about the sector right now is that other investors have caught on and started bidding up the price. There is one other worrying factor for the ETF. The average volume on it is quite dreadful. There are two ways to look at that issue. One is to bemoan the weak trading volume increasing the bid-ask spread. The other option is to look for ways to trade the ETF without commissions and then to keep using limit orders to try to enter at an attractive price. The ETF has far more liquidity problems than the underlying securities and the low expense ratio is fairly attractive for investors looking for a long term holding. The biggest caution here is that investors should avoid using any “market” orders. Only trade this one with limit orders.